IDENIX PHARMACEUTICALS, INC. 18,310,000 Shares of Common Stock Underwriting AgreementIdenix Pharmaceuticals Inc • April 11th, 2011 • Pharmaceutical preparations • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by J.P. Morgan Securities LLC (the “Underwriter”), of common stock, $0.001 par value, of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
CONCURRENT PRIVATE PLACEMENT STOCK PURCHASE AGREEMENT by and between NOVARTIS PHARMA AG and IDENIX PHARMACEUTICALS, INC.Concurrent Private Placement Stock Purchase Agreement • April 11th, 2011 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Concurrent Private Placement Stock Purchase Agreement (this “Agreement”) is made as of the 8th day of April, 2011, by and between Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Novartis Pharma AG (the “Investor”).
